| Literature DB >> 27809765 |
Kyle M Schachtschneider1,2, Yingkai Liu1,3, Laurie A Rund1, Ole Madsen2, Rodney W Johnson1, Martien A M Groenen2, Lawrence B Schook4,5.
Abstract
BACKGROUND: Iron deficiency is a common childhood micronutrient deficiency that results in altered hippocampal function and cognitive disorders. However, little is known about the mechanisms through which neonatal iron deficiency results in long lasting alterations in hippocampal gene expression and function. DNA methylation is an epigenetic mark involved in gene regulation and altered by environmental factors. In this study, hippocampal DNA methylation and gene expression were assessed via reduced representation bisulfite sequencing and RNA-seq on samples from a previous study reporting reduced hippocampal-based learning and memory in a porcine biomedical model of neonatal iron deficiency.Entities:
Keywords: Angiogenesis; DNA methylation; Gene expression; Hypoxia; Neonatal iron deficiency; Neurodevelopment; Porcine biomedical model; RNA-seq; RRBS
Mesh:
Substances:
Year: 2016 PMID: 27809765 PMCID: PMC5094146 DOI: 10.1186/s12864-016-3216-y
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Visualization of DEGs. a Total number of DEGs, including those up- and down-regulated in the iron deficient compared to the control group. b Heatmap of the normalized expression level of the 192 DEGs for each sample, represented as z-scores. Dendrograms represent relationships between samples (columns) and genes (rows) based on complete linkage clustering
Fig. 2GO terms and pathways enriched for DEGs in the iron deficient group. a. GO terms related to response to hypoxia that were enriched for DEGs up-regulated in the iron deficient group. b. DEGs associated with enriched GO terms related to response to hypoxia. c. GO terms and pathways related to angiogenesis that were enriched for DEGs up-regulated in the iron deficient group. d. DEGs associated with enriched GO terms and pathways related to angiogenesis. e. GO terms and pathways related to genes located within the extracellular matrix that were enriched for DEGs up-regulated in the iron deficient group
Fig. 3Enriched GO terms and pathways related to neurological functions in the iron deficient group. a GO terms and pathways enriched for DEGs related to neurodevelopment and function. b DEGs associated with enriched GO terms and pathways related to neurodevelopment and function
Fig. 4Influence of SNPs on differential methylation analysis. The number of DM CpG sites detected before and after SNP removal are displayed in blue, while the proportion of SNPs at DM CpG sites and all covered CpG sites are displayed in red. *denotes P-value < 1 x 10−15
Fig. 5Distribution and similarity of hippocampal DNA methylation patterns. Distribution of a CpG and b non-CpG site methylation in the iron deficient and control samples. Multidimensional scaling plot of Bray-Curtis dissimilarities between samples for c all CpG sites and d all non-CpG sites. *denotes p-value < 0.05
Fig. 6Distribution and similarity of DM sites across groups. Number of DM, hypomethylated, and hypermethylated a CpG and b non-CpG sites detected between the iron deficient and control group. Heatmap of the methylation level for a 853 DM CpG and b 99 DM non-CpG sites for each sample, represented as z-scores. Dendrograms represent relationships between samples based on complete linkage clustering. Multidimensional scaling plot of Bray-Curtis dissimilarities between samples for c DM CpG sites and d DM non-CpG sites
Fig. 7Distribution of DM sites in relation to genomic features. Ratio of DM to covered a CpG and b non-CpG sites in relation to genomic features. Distribution of c DM CpG and d DM non-CpG sites in DEG regions (including 10 kb upstream of TSS) compared to all genes
DM sites associated with DEGs
| Gene | Chr | Start | Stop | Strand | Control expression (FPKM) | Iron deficient expression (FPKM) | Log2 fold change | CpG site | % Methylation difference |
|
| 6 | 125,964,963 | 126,223,426 | − | 220.095 | 108.314 | −1.02291 | 126,222,882 | 27.13 % |
|
| 13 | 218,086,392 | 218,088,850 | + | 6.0639 | 16.1761 | 1.41555 | 218,086,634 | 46.84 % |
|
| 14 | 116,376,967 | 116,425,960 | − | 0.787778 | 2.73519 | 1.79578 | 116,377,431 | 25.47 % |
|
| 7 | 93,628,494 | 93,828,585 | − | 61.2676 | 31.3412 | −0.967065 | 93,828,414 | 29.24 % |
|
| 14 | 80,010,893 | 80,098,908 | + | 7.68495 | 12.5631 | 0.709085 | 80,060,756 | 34.05 % |
|
| 5 | 67,005,340 | 67,078,256 | + | 2.61282 | 9.17948 | 1.81281 | 67,050,813 | −39.15 % |
|
| X | 124,748,953 | 125,078,245 | − | 21.3711 | 8.641 | −1.30639 | 125,076,126 | 25.18 % |
|
| X | 108,566,657 | 108,871,722 | + | 3.18817 | 6.73597 | 1.07916 | 108,591,537 | 37.11 % |
|
| X | 108,566,657 | 108,871,722 | + | 3.18817 | 6.73597 | 1.07916 | 108,591,463 | −35.23 % |
|
| X | 108,566,657 | 108,871,722 | + | 3.18817 | 6.73597 | 1.07916 | 108,564,261 | −25.29 % |
|
| X | 108,566,657 | 108,871,722 | + | 3.18817 | 6.73597 | 1.07916 | 08,564,264 | −37.58 % |
| Gene | Chr | Start | Stop | Strand | Control expression (FPKM) | Iron deficient expression (FPKM) | Log2 fold change | Non-CpG site | % Methylation difference |
|
| 3 | 1,066,675 | 1,085,568 | − | 2.73823 | 6.46233 | 1.23881 | 1,084,014 | 44.53 % |
The first 11 lines represent DM CpG sites associated with DEGs, while the last line represents a single DM non-CpG site associated with a DEG. % methylation difference is the observed change in methylation in the deficient group relative to the control group. Log2 fold changes are the observed change in expression in the deficient group relative to the control group. Expression levels are represented as fragments per kilobase of transcript per million fragments mapped (FPKM)